medmix AG
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of medmix AG generated cash of $56,100,000, which is more than the previous year. Cash used in financing activities reached the amount of -$153,800,000 last year. Net change in cash is therefore -$182,900,000.
Cash Flow
| 2018 | 94.2M | -33.2M | -46.4M |
|---|---|---|---|
| 2019 | 89.1M | -39.6M | -59M |
| 2020 | 50.6M | 4.4M | -42.9M |
| 2021 | 87.3M | -3.3M | 111.6M |
| 2022 | 47.6M | -57M | 116.1M |
| 2023 | 56.1M | -80.6M | -153.8M |
MEDX.SW Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 313.5M | 209.8M | 14.8M | 4.4M | 16.3M | 3M |
Operating activities | ||||||
Net income | 700K | 11.6M | 44M | 9.6M | 25.2M | 52.2M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 55.4M | 51.1M | 51.7M | 43.1M | 43.2M | 42.8M |
Stock-based compensation expense | 2.5M | 1.8M | 1.1M | 500K | 400K | 200K |
| Deferred income tax benefit | 2.5M | 1.8M | 1.1M | 500K | 400K | 200K |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 2M | -38.9M | -2.9M | 8M | 14M | 7.8M |
Inventories | 400K | -30.5M | -17M | 4.3M | 400K | 1.1M |
Accounts payable | -3.3M | 10M | 12.1M | -8M | -3.5M | 7.1M |
Cash generated by operating activities | 56.1M | 47.6M | 87.3M | 50.6M | 89.1M | 94.2M |
Investing activities | ||||||
Purchases Of Investments | -6.3M | -3.3M | -200K | -27.2M | -60.3M | -17.4M |
Investments In Property Plant And Equipment | -46.4M | -38.6M | -31.9M | -43.1M | -36.2M | -30M |
Acquisitions Net | -31.1M | -16.7M | -2.7M | 2.2M | 3M | 2.3M |
Cash generated by investing activities | -80.6M | -57M | -3.3M | 4.4M | -39.6M | -33.2M |
Financing activities | ||||||
Common Stock Issued | 0 | 0 | 294.7M | 0 | 0 | 0 |
Payments for dividends | -15M | -15M | -41.3M | -52M | -55M | -47.2M |
Repurchases of common stock | -3.1M | -6.1M | -6.5M | 0 | 0 | 0 |
Repayments of term debt | -123.6M | 145.9M | -501M | -22.2M | -5.2M | -25M |
Cash used in financing activities | -153.8M | 116.1M | 111.6M | -42.9M | -59M | -46.4M |
Net Change In Cash | -182.9M | 103.7M | 195M | 10.4M | -11.8M | 13.2M |
Cash at end of period | 130.6M | 313.5M | 209.8M | 14.8M | 4.5M | 16.2M |
| Data source | Data source | Data source | Data source | Data source | Data source |